Nemaura Medical (NMRD) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NMRD vs. UTRS, MOTS, VIVE, DRTSW, ANZUW, ATAKW, BBLGW, HSCSW, BEATW, and LUCYWShould you be buying Nemaura Medical stock or one of its competitors? The main competitors of Nemaura Medical include Minerva Surgical (UTRS), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), and Innovative Eyewear (LUCYW). These companies are all part of the "medical equipment" industry. Nemaura Medical vs. Its Competitors Minerva Surgical Motus GI Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Heart Test Laboratories HeartBeam Innovative Eyewear Nemaura Medical (NASDAQ:NMRD) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, valuation, dividends and risk. Does the media refer more to NMRD or UTRS? In the previous week, Minerva Surgical had 1 more articles in the media than Nemaura Medical. MarketBeat recorded 1 mentions for Minerva Surgical and 0 mentions for Nemaura Medical. Nemaura Medical's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score. Company Overall Sentiment Nemaura Medical Neutral Minerva Surgical Neutral Which has better valuation & earnings, NMRD or UTRS? Nemaura Medical has higher earnings, but lower revenue than Minerva Surgical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNemaura Medical$3.02K0.00-$14.14M-$0.39N/AMinerva Surgical$51.69M0.00-$34.11MN/AN/A Is NMRD or UTRS more profitable? Company Net Margins Return on Equity Return on Assets Nemaura MedicalN/A N/A N/A Minerva Surgical N/A N/A N/A Which has more risk and volatility, NMRD or UTRS? Nemaura Medical has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500. Comparatively, Minerva Surgical has a beta of 3.53, meaning that its share price is 253% more volatile than the S&P 500. Do institutionals & insiders hold more shares of NMRD or UTRS? 4.4% of Nemaura Medical shares are held by institutional investors. 40.4% of Nemaura Medical shares are held by insiders. Comparatively, 8.5% of Minerva Surgical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryNemaura Medical and Minerva Surgical tied by winning 3 of the 6 factors compared between the two stocks. Get Nemaura Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NMRD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NMRD vs. The Competition Export to ExcelMetricNemaura MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$4K$81.67M$5.79B$10.15BDividend YieldN/AN/A5.69%4.60%P/E Ratio0.0011.4074.5925.92Price / SalesN/A113.16453.5485.33Price / CashN/A18.4137.0859.91Price / BookN/A10.9812.156.29Net Income-$14.14M-$26.48M$3.28B$270.77M Nemaura Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMRDNemaura Medical0.7093 of 5 starsN/AN/AN/A$4K$3.02K0.0040UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160MOTSMotus GI0.0321 of 5 starsN/AN/AN/A$1K$319K0.0030Gap DownVIVEViveve MedicalN/A$0.00flatN/AN/A$1K$6.83M0.0070DRTSWAlpha Tau MedicalN/A$0.30+7.1%N/A+58.9%$0.00N/A0.0080Gap DownANZUWAnzu Special Acquisition Corp IN/A$0.04flatN/A-41.9%$0.00N/A0.002Gap UpATAKWAurora Technology AcquisitionN/A$0.02+5.8%N/A+51.5%$0.00N/A0.00N/AGap UpBBLGWBone BiologicsN/A$10.79flatN/AN/A$0.00N/A0.002Positive NewsGap DownHSCSWHeart Test LaboratoriesN/A$0.06flatN/AN/A$0.00$4.35K0.0010Gap DownBEATWHeartBeamN/A$0.27-6.9%N/A-57.8%$0.00N/A0.005Gap DownLUCYWInnovative EyewearN/A$0.09+4.1%N/A+3.1%$0.00$1.98M0.009Gap Up Related Companies and Tools Related Companies UTRS Competitors MOTS Competitors VIVE Competitors DRTSW Competitors ANZUW Competitors ATAKW Competitors BBLGW Competitors HSCSW Competitors BEATW Competitors LUCYW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMRD) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemaura Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nemaura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
